SURVEY ON THE RATE, EXTENT OF HYPERTENSION AND SOME FACTORS RELATED IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT KIEN GIANG GENERAL HOSPITAL IN 2021-2022

Truong Dong Nguyen1,, Thi Tuyet Ngan Doan2, Hoang Khai Truong3
1 An Minh District Medical Center, Kien Giang Province
2 Can Tho University of Medicine and Pharmacy
3 Kien Giang General Hospital

Main Article Content

Abstract

Background: Advanced chronic kidney disease often presents with hypertension, especially after stage 3 of the disease. In contrast, hypertension is common in all forms of congenital or acquired nephropathy, causing kidney damage and accelerating the decline in renal function in patients. Objectives: 1. Determine the rate and extent of hypertension in patients with chronic kidney diseases; 2. Investigate some factors related to hypertension in patients with chronic kidney disease. Materials and methods: Prospective study on 192 chronic kidney disease patients diagnosed with chronic kidney disease according to the guidelines of the Council of Kidney Disease Improving Global Outcome - KDIGO (2012). Diagnosis and treatment of hypertension with drugs for chronic kidney disease according to Vietnam National Heart Association 2018. Results: The rate of hypertension in patients with chronic kidney disease was 93.2%. In which, hypertension level I accounted for 44.1%, level II made up 34.1% and grade III composed 21.8%. The association between age ≥60 years, sex, chronic kidney disease stage, obesity, ACR and hypertension rate in chronic kidney disease patients has not been recorded. Conclusions: The prevalence of hypertension in patients with chronic kidney disease accounted for the majority. Extent of hypertension in patients with chronic kidney disease is mostly mild. The association between age ≥60 years, sex, chronic kidney disease stage, obesity, ACR and hypertension rate in chronic kidney disease patients have not been recorded.

Article Details

References

1. Bệnh viện Bình Dân (2017), Bệnh thận mạn. Hướng dẫn chẩn đoán và điều trị năm 2017-Tập 3 Nội khoa – Gây mê hồi sức, Sở Y tế TP. Hồ Chí Minh, tr.218-228.
2. Nguyễn Hồng Hà, Trần Vân Thy (2018), Nghiên cứu một số yếu tố liên quan tình trạng loãng xương trên bệnh nhân suy thận mạn điều trị tại Bệnh viện Trường Đại học Y Dược Cần Thơ. Tạp chí Y Dược Cần Thơ, 11-12, tr.1-7.
3. Hội Tim Mạch học Quốc gia Việt Nam (2018), Khuyến cáo về chẩn đoán và điều trị tăng huyết áp 2018, Hà Nội.
4. Võ Tam (2016), Dịch tễ học bệnh thận mạn. Bệnh thận mạn: bệnh học, chẩn đoán và điều trị, tr.40-61.
5. Võ Tam, Nguyễn Văn Tuấn (2017), Tăng huyết áp trong bệnh thận mạn: Những khuyến cáo điều trị theo Kdigo 2012, Ngày đăng 01/03/2017, [Ngày trích dẫn 21/04/2021], lấy từ URL:
http://vientimmach.vn/vi/chi-dao-tuyen-va-bv-ve-tinh/tang-huyet-ap-trong-benh-than-mannhung-khuyen-cao-dieu-tri-theo-kdigo-2012.html
6. Mai Huỳnh Ngọc Tân, Nguyễn Như Nghĩa (2019), Nồng độ acid uric máu ở bệnh nhân bệnh thận mạn giai đoạn chưa lọc máu định kì tại Bệnh viện Đa khoa Trung ương Cần Thơ. Tạp chí Y Dược Cần Thơ, 11, tr.1-8.
7. Arora P., Vasa P., Brenner D., et al. (2013), Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ, 185(9), pp.417-423.
8. Khanam M.A, Kitsos A., et al. (2019), Association of continuity of care with blood pressure control in patients with chronic kidney disease and hypertension. The Royal Australian College of General Practitioners, 48(5), pp.300-306.
9. Lora C.M., Ricardo A.C., et al. (2020), Prevalence, Awareness, and Treatment of Hypertension in Hispanics/Latinos With CKD in the Hispanic Community Health Study/Study of Latinos. Kidney Medicine, 2(3), pp.332-340.
10. Monhart V. (2013), Education in Cardiology: Hypertension and chronic kidney diseases. Cor et Vasa, 55, pp.397-402.
11. Schneider MP, Hilgers KF, Schmid M, et al. (2018), Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study. PLoS ONE, 13(8), e0202604.
12. Sinha A.D., Agarwal R. (2019), Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD. Clin J Am Soc Nephrol, 14, pp.757-764.
13. USRDS (2020), Chapter 1: CKD in the General Population. Chronic Kidney Disease, Annual Data Report.
14. USRDS (2020), Chapter 3: Morbidity and Mortality in Patients With CKD. Chronic Kidney Disease, Annual Data Report.
15. Varma P.P (2015), Prevalence of chronic kidney disease in India – where are we heading?. Indian Journal of Nephrology, 25(3), pp.133-135.